Data as of Oct 28, 2026.

vsCompare their flowsaskIQ about these two fundsAsk the committee about these two funds
Across categories

VBK vs XBI: Differences, Returns & Fees

Share
Share on XDownload as PDF

Over the year to Oct 28, 2026, VBK returned +10.3% to XBI's +41.2%, and VBK charges 0.05% to XBI's 0.35%.

askIQ about this page

askIQ about VBK and XBI

Net assets: $22.8bn on Sep 30, 2026 for Vanguard Morningstar Small-Cap Growth ETF, and $10.3bn on Oct 27, 2026 for State Street SPDR S&P Biotech ETF.

At a glance
+10.3%
VBK total return, 1 year
+41.2%
XBI total return, 1 year
0.05%
VBK expense ratio
0.35%
XBI expense ratio

Pair scorecard

VBK costs 0.30 points a year less; their one-year returns differ by 30.9 points; VBK is 2.2 times larger.

VBK vs XBI: Differences, Returns & Fees
MeasureVBKXBI
Return
Total return, 1 year+10.3%+41.2%
Drawdown
Below its high8.0%, high on Aug 17, 2026
Below its all-time high8.9%, high on Feb 8, 2021
Benchmark
What it tracksMorningstar US Small Cap Growth IndexBiotech
Cost and size
Expense ratio0.05%0.35%
Net assets, as of Sep 30, 2026$22.8bn$10.4bn
Active share vs the S&P 50098%
Holdings
Holdings in common11%
Top ten holdings, share of the fund12.2%18%

Holdings in common uses holdings dated Sep 30, 2026 and Oct 27, 2026. Method

Risk and return

Feb 17, 2006 to Oct 23, 2026 · 1,079 weekly returns
VBK XBI
Return
Total return edge XBI +496.6% +817.9%
Annualized edge XBI +9.0% +11.3%
Price return edge XBI +418.2% +767.9%
Risk
Volatility edge VBK 22.8% 29.2%
Max drawdown edge VBK (slight) −57.8% −61.5%
Risk-adjusted
Sharpe edge XBI (slight) 0.42 0.45
Sortino edge XBI 0.59 0.66
Calmar edge XBI 0.16 0.18
Reading

XBI returned more: +817.9% to +496.6%. VBK swung less: 22.8% to 29.2%. VBK fell slightly less at its worst: −57.8% to −61.5%.

Full scorecard

9 measures, with how each is measured
Open ↓
Risk and return: VBK vs XBI: Differences, Returns & Fees
MeasureVBKXBIEdgeHow it is measured
Return
Total return+496.6%+817.9%XBIPrice change plus distributions, reinvested.
Annualized+9.0%+11.3%XBITotal return as a yearly rate.
Price return+418.2%+767.9%XBIPrice change alone, distributions left out.
Risk
Volatility22.8%29.2%VBKSpread of weekly returns, annualized. Lower is steadier.
Downside deviation16.0%20.0%VBKLike volatility, counting only weeks below the Treasury bill rate.
Max drawdown−57.8%−61.5%VBK (slight)Deepest fall from a high to the low after it.
Risk-adjusted
Sharpe0.420.45XBI (slight)Return above Treasury bills per unit of volatility.
Sortino0.590.66XBIReturn above Treasury bills per unit of downside deviation.
Calmar0.160.18XBIAnnualized return divided by the max drawdown.

Computed by ETFIQ from Tiingo daily prices and ETFIQ's distribution records, 1,079 weekly returns. Cash rate: the 13-week Treasury bill.

What they share

11%

By the books each fund has filed, VBK and XBI hold 11% of their money in the same securities at the same weight. Holdings dated Sep 30, 2026 and Oct 27, 2026.

0 half 100%

half

11% in common

Positions both hold · largest shared weight first VBK XBI
Natera Inc 1.61% 1.82%
Revolution Medicines Inc 1.19% 1.31%
Incyte Corp 0.60% 1.35%
Roivant Sciences Ltd 0.53% 1.28%
Neurocrine Biosciences Inc 0.41% 1.38%
Exelixis Inc 0.39% 1.64%
Twist Bioscience Corp 0.37% 1.86%
Halozyme Therapeutics Inc 0.36% 1.75%
Insmed Inc 0.36% 1.08%
BioMarin Pharmaceutical Inc 0.33% 1.26%
United Therapeutics Corp 0.33% 1.71%
Bridgebio Pharma Inc 0.33% 1.33%
Only in one fund ↓
Only in VBK
SLCMT1142 2.09%
Twilio Inc 1.28%
Illumina Inc 1.18%
Everpure Inc 1.18%
Okta Inc 1.00%
EMCOR Group Inc 0.95%
Credo Technology Group Holding Ltd 0.94%
TechnipFMC PLC 0.76%
Only in XBI
MODERNA INC 2.24%
BIOGEN INC 1.75%
AMGEN INC 1.68%
ABBVIE INC 1.67%
SPYRE THERAPEUTICS INC 1.67%
GILEAD SCIENCES INC 1.60%
REGENERON PHARMACEUTICALS 1.48%
VERTEX PHARMACEUTICALS INC 1.46%
Check overlap with more funds →

Side by side

VBK Vanguard Morningstar Small-Cap Growth ETF XBI State Street SPDR S&P Biotech ETF
Where it sits Stock ETF Thematic ETF
What it is Tracks an index of Small-Cap Growth Biotech
Total return, 1 year +10.3% +41.2%
Expense ratio 0.05% 0.35%
Already in the S&P 500 10.2% 13.2%
Holdings 554 165
Net assets, VBK as of Sep 30, 2026 and XBI as of Oct 27, 2026 $22.8bn $10.3bn

VBK and XBI on the fields both publish, as of Oct 28, 2026. Source: ETFIQ.

Client brief · page 1 of 2 Report BR-44159E59F5

VBK and XBI do different jobs. What does each one do in a portfolio?

  1. What each follows. VBK follows Morningstar US Small Cap Growth Index and XBI follows Biotech.
  2. Holdings in common. 11% of the weight is in the same securities (holdings dated Sep 30, 2026 and Oct 27, 2026).
  3. One-year total return. Over 1 year to Oct 28, 2026 VBK returned +10.3% and XBI +41.2% with distributions reinvested, a gap of 30.9 points.

Data as of Oct 28, 2026.

The two-page PDF for this pair is coming. Save the comparison to follow its changes. Free. It needs an email sign-in, once.

Your saved page · Privacy.

Alert

XBI flows, by email on Sundays.

One-click unsubscribe. See Privacy.

About each fund
VBK

VBK tracks an index of Small-Cap Growth. Over the year to Oct 28, 2026 it returned +10.3% with distributions reinvested. The prospectus expense ratio is 0.05% a year. By its holdings published by its issuer as of Sep 30, 2026, 10% of the fund by weight is stocks the S&P 500 also holds, across 554 positions, with the top ten at 12.2%. It sat 8.0% below its high of Aug 17, 2026 on Oct 28, 2026.

XBI

By weight, 13% of XBI's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 98%. The top ten holdings are 18% of the fund across 165 positions, as published by its issuer for Oct 27, 2026. Over the year to Oct 28, 2026 the fund returned +41.2% with distributions reinvested. It sits 8.9% below its all-time high of Feb 8, 2021.

Questions people ask

Are VBK and XBI in the same category?
VBK is a stock ETF and XBI is a thematic ETF, so they do different jobs. The table compares what both publish: return, cost and holdings.
Which returned more over the last year, VBK or XBI?
In the year to Oct 28, 2026, with distributions reinvested, VBK returned +10.3% and XBI +41.2%.
Which is cheaper, VBK or XBI?
VBK is cheaper, by 0.30 percentage points a year. That is about $30 on $10,000 held for a year. Fees come from each fund's prospectus.
How much do VBK and XBI overlap with the S&P 500?
By their latest filed holdings, 10% of VBK and 13% of XBI by weight is stocks the S&P 500 already holds.
Other comparisons
Cite this pageCitation, APA and Markdown

ETFIQ, VBK against XBI, data as of Oct 28, 2026. https://etfiq.com/compare/any/vbk-vs-xbi

Open data →

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.